Table 5.
Prognostic factors by univariate analysis and multivariate analysis.
| Prognostic factors | Univariate analysis | Multivariate analysis | |
|---|---|---|---|
| p | Relative risk (95% CI) | p | |
| Male | 0.55 | — | — |
| Age (<40) | 0.15 | — | — |
| PS (0) | 0.012 | — | 0.54 |
| Number of involved organs (<3) | 0.013 | 0.31 (0.15–0.65) | 0.0019 |
| Head and neck | 0.28 | — | — |
| Intra-abdomen | 0.25 | — | — |
| Retroperitoneum | 0.17 | — | — |
| Lung | 0.34 | — | — |
| Liver | 0.30 | — | — |
| Bone | 0.60 | — | — |
| Lymph node | 0.84 | — | — |
| No bulky mass (<5 cm) | 0.009 | 0.27 (0.12–0.60) | 0.0013 |
| Pretreatment | 0.73 | — | — |
| Normal, N/l | 0.44 | — | — |
| Normal Hb level (≧11.6 g/dl) | 0.18 | — | — |
| Normal LDH level (<222 mg/dl) | 0.61 | — | — |
| Normal ALP level (<322 IU/l) | 0.12 | — | — |
| Normal CRP level (<0.14 mg/dl) | 0.020 | 0.43 (0.20–0.93) | 0.032 |